# Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube

> **NCT04776135** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 36 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** MT-1186

## Key facts

- **NCT ID:** NCT04776135
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-26
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04776135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04776135, "Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04776135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*